Skip to main navigation Skip to search Skip to main content

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis

Project: Research

Project Details

StatusActive
Effective start/end date08/9/22 → 01/6/27

Funding

  • Vertex Pharmaceuticals Incorporated: $251,761.71